Celyad Oncology SA
CYADN/A
NASDAQBiotechnology🇺🇸North America
Drugs in Pipeline
3
Phase 3 Programs
2
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
CYAD News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
Injection of C3BS-CQR-1
Heart Failure
C-Cure
Heart Failure Class II or III
NKR-2
AML
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Injection of C3BS-CQR-1 | Phase 3 | Heart Failure | - | - |
C-Cure | Phase 3 | Heart Failure Class II or III | - | - |
NKR-2 | Phase 2 | AML | - | - |
Heart Failure Class II or III
1 drug in this indication
AML
1 drug in this indication
Heart Failure
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply